Orphan regulations for orphan drug development in India

Asian Journal of Pharmaceutics

Volumn 8, Issue 2, 2014, Pages 130-132

  Reddy, D Saikiran ^a   Pramodkumar, T M ^a   Reddy, Yugendar ^a   Sirisha, K ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Orphan diseases; orphan drug; orphan drugs act

Indexed keywords

ORPHAN DRUG;

AUSTRALIA; DRUG INDUSTRY; DRUG LEGISLATION; EUROPE; FINANCIAL MANAGEMENT; GILLES DE LA TOURETTE SYNDROME; GLIOBLASTOMA; GOVERNMENT; INDIA; JAPAN; NOCARDIOSIS; RARE DISEASE; REVIEW; UNITED STATES;

EID: 84903194107     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.134958     Document Type: Review

References (5)

1. FDA. Available from: Http://www.fda.gov/downloads/ForConsumers/ ConsumerUpdates/ucm107301.pdf. [Last accessed on 2013 Jul 20].
2. Tapray blog. Available from: Http://www.tapanray. i n / the-concept-of-orphan-drugs-for-orphan-diseases-is-orphan-in-india/. [Last accessed on 2013 May 10].
3. Pharma Express. The eternal orphan. Available from: Http://www. expresspharmaonline.com/20080831/research01.shtml. [Last accessed on 2013 Apr 13]. (Accessed on April 2013)
4. Sharma A, Jacob A, Tandon M, Kumar D. Orphan drug: Development trends and strategies. J Pharm Bioallied Sci 2010;2:290-9.
5. Orphanet. Available from: Http://www.orpha.net/consor/cgi-bin/ Education-AboutOrphanDrugs.php?lng=EN and stapage=ST-EDUCATION-EDUCATION- ABOUTORPHANDRUGS-COMPARISON. [Last accessed on 2013 May 13].